Kapoose Creek Bio Acquires Exclusive License to Adapsyn Bioscience’s World-Leading AI Technology for Drug Development
30 Oct 2024
ANCOUVER, BC, October 30, 2024 /CNW/ – Kapoose Creek Bio, a biotechnology company leveraging AI for drug discovery from nature, today announced an exclusive license of Adapsyn Bioscience’s preeminent chemical informatics platform, and the acquisition of its state-of-the art drug discovery lab and globally recognized talent.